Business Context and Reporting Period
Company: IRADIMED CORP (IRMD)
Filing Type: Form 8-K (Current Report)
Report Date: April 29, 2022
Reporting Period: First quarter ended March 31, 2022
This filing serves as a notification that the company issued a press release announcing its financial results for the first quarter of 2022. The press release is included as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for the actual figures.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific details regarding material changes in financial condition or operations compared to prior periods. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release but does not include the text of management's commentary, guidance, or outlook within this document.
Risks and Contingencies: No specific risks or contingencies are detailed in this cover sheet. The filing includes a standard disclaimer that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated April 29, 2022) for actual Q1 2022 revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the press release.
- Check for any updated forward-looking guidance or operational outlook provided in the press release.
- Confirm the status of the company as an emerging growth company (indicated as checked in the filing).